CVinter > CVintra! [Power / Sample Size]

posted by Helmut Homepage – Vienna, Austria, 2007-10-15 18:15 (6827 d 23:49 ago) – Posting: # 1190
Views: 13,542

Dear stat_be!

❝ […] I have used proc glm for this and here MSE_Sub(seq) is less than MSE_residual so inter subject CV% can not be calculated. This is practical data obtained. […] Same thing happened in the data of Cmax where %CV_inter < %CV_intra.


It would be nice, if you could provide us with you Cmax data!

Just a hint from Pharsight’s WinNonlin knowledge base:
Solution for WinNonlin Bioequivalence Warning 11094: Negative final variance component
The negative final Variance Component warning most likely indicates that, if using Subj(Seq) as a random effect, the within-subject variance (residual) is greater than the between-subject variance. Probably a more appropriate model is to move Subj(Seq) out of the random model and into the fixed model, i.e.,

Sequence+Subject(Sequence)+Formulation+Period.

To do this, use the following steps:
  1. Start BE Wizard.
  2. Specify reference formulation → Next
  3. Specify dependent variable, e.g. Cmax → Next
  4. Click Delete Random to remove Subject(Sequence) component → Back
  5. Add Subject(Sequence) to the Fixed effects model as shown above
  6. Click Calculate
You can reformulate you model in SAS accordingly.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
138 visitors (0 registered, 138 guests [including 15 identified bots]).
Forum time: 18:05 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5